New York, NY, July 26, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine, and Combined Drug) and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024”. According to the report, global Alzheimer’s Drugs Market was valued at approximately USD 3.64 billion in 2017 and is expected to generate revenue of around USD 5.66 billion by end of 2024, growing at a CAGR of around 8% between 2018 and 2024.
Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia which includes a broad group of brain diseases, such as problems with memory, thinking, and behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dementia. Many researchers consider an increase in the level of protein amyloid in the brain is one of the causes of Alzheimer disease. Older age is the prominent cause of Alzheimer's, whereas there are also some genetic and some other causes of Alzheimer diseases. The exact cause of Alzheimer’s disease is still unknown.
Browse through 90 Tables & 12 Figures spread over 110 Pages and in-depth TOC on "Global Alzheimer’s Drugs Market Size & Share 2017: Industry Type, Growth, Segments Analysis and Forecast 2024”.
Request Free Sample Report of Global Alzheimer’s Drugs Market Report @ https://www.zionmarketresearch.com/sample/alzheimers-drugs-market
The global Alzheimer’s market is mainly driven by the growing occurrence of diseases in developed countries specifically in the Western region. Additionally, the prevalence of some neurodegenerative diseases such as dementia, growing occurrence of diseases, firm government encouragement for Alzheimer’s drug development, and growing alertness about the treatment of Alzheimer’s disease is resulting into increased demand for Alzheimer’s drugs market. However, high prices of the advance drugs may create restraints in underdeveloped countries. Also, awareness about Alzheimer’s disease in the developing regions remains restricted, which has resulted in unbalanced healthcare systems and obstructive research infrastructure. In Asia Pacific region, growing encouragement for mental care by governments is anticipated to drive the Alzheimer’s drugs market in the near future.
The Alzheimer’s drugs market is classified based on the drug class, distribution channel, and region. On the basis of drug class, market divided into memantine, cholinergic, and combined drug. Memantine drug segment anticipates leading the market in the forecast period. On the basis of the distribution channel, the market is divided into hospital pharmacy, retail pharmacy, and online sales.
Download Free Report Brochure: https://www.zionmarketresearch.com/requestbrochure/alzheimers-drugs-market
North America was the largest regional market and is expected to show significant growth in the years to come. In North America, Alzheimer’s drugs market is growing owing to the occurrence of diseases in developed Western countries and the presence of global players.
Europe represents developed regional markets for Alzheimer’s drugs market and is expected to see the rapid growth in the years to come.
Browse the full "Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine, and Combined Drug) and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/alzheimers-drugs-market
Growth in the Asia Pacific market is expected to be driven by region due to growing awareness about the treatment of Alzheimer’s in the Asia Pacific region; this region is likely to be a key contributor to the global Alzheimer's drugs market in the coming years.
In the Middle East & Africa; African region is projected to register moderate growth rate due to lack of awareness. Latin America is another important regional market and is expected to experience moderate growth over the forecast period. Thus, all the above-mentioned parameters are expected to support the market growth in this region.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/alzheimers-drugs-market
Some of the key players in Alzheimer’s drugs are Ono Pharmaceutical, Johnson & Johnson, Daiichi Sankyo Company Limited, H Lundbeck A/S, and Eisai Co. Ltd., among others.
Directly Purchase a copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/alzheimers-drugs-market
This report segments the global Alzheimer’s drugs market as follows:
Global Alzheimer’s Drugs: by Drug Class
- Cholinergic
- Memantine
- Combined Drug
Global Alzheimer’s Drugs: by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
Global Alzheimer’s Drugs: by Region
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- In Vitro Fertilization (IVF) Market: https://www.zionmarketresearch.com/report/in-vitro-fertilization-market
- Active Wound Care Market: https://www.zionmarketresearch.com/report/active-wound-care-market
- Macrolide Drugs Market: https://www.zionmarketresearch.com/report/macrolide-drugs-market
- Equine Healthcare Market: https://www.zionmarketresearch.com/report/equine-healthcare-market
- Monoclonal Antibody Therapeutics Market: https://www.zionmarketresearch.com/report/monoclonal-antibody-therapeutics-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com
Contact Us:
Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com
Blog: http://zmrblog.com